摘要
对恶性肿瘤进行放疗、化疗、分子靶向治疗及免疫治疗时可能对甲状腺造成损害,引起继发性甲减,尤其儿童患者治疗后远期可出现甲状腺癌。因此,对恶性肿瘤进行内科治疗时需要评估甲状腺功能,治疗后应该密切检测甲状腺功能的变化。
Malignant tumor therapies(radiotherapy,chemotherapy,molecular targeted therapy,and immunotherapy)can damage the thyroid gland,cause secondary hypothyroidism,and especially induce thyroid cancer after long-term treatment in pediatric patients.Therefore,thyroid function should be assessed before the medical treatment of malignant tumors and monitored closely after the start of treatment.
作者
姚兰(综述)
徐勇
蒋成霞(审校)
YAO Lan;XU Yong;JIANG ChengXia(Department of Endocrine,The No.2 People’s Hospital of YiBin;Department of Endocrine,The Affiliated Hospital of Southwest Medical University,YinBin 644000,Sichuan Province,China)
出处
《西南医科大学学报》
2020年第1期82-85,共4页
Journal of Southwest Medical University
关键词
恶性肿瘤
甲状腺
放疗
化疗
分子靶向治疗
免疫治疗
Malignant tumor
Thyroid
Radiotherapy
Chemotherapy
Molecular targeted therapy
Immunotherapy
